Stockreport

ImmunoPrecise Antibodies (IPA) Reports Financial Results and Recent Business Highlights for First Quarter Fiscal Year 2025

ImmunoPrecise Antibodies Ltd.  (IPA) 
PDF Achieves $5.3 Million First Quarter Revenue, Reaches Milestone Developing Antibodies End-to-End Using LENSai VICTORIA, British Columbia--(BUSINESS WIRE)--IMMUNOPRECIS [Read more]